Explore another way you may receive treatment.

Potential OPDIVO® (nivolumab) user dancing with his wife in the living room.
Potential OPDIVO® (nivolumab) user dancing with his wife in the living room.

Clinical trial results for
advanced kidney
cancer, or renal cell
carcinoma (RCC)

See results for OPDIVO immunotherapy, alone or in combination with other therapies

Actor portrayals.

Advanced kidney cancer

OPDIVO + YERVOY

For certain adults with previously untreated kidney cancer that has spread (advanced RCC)

Advanced kidney cancer

OPDIVO + CABOMETYX® (cabozantinib)

For certain adults with previously untreated kidney cancer that has spread (advanced RCC)

Previously treated advanced kidney cancer

OPDIVO

For certain adults with kidney cancer (RCC) when your cancer has spread or grown after treatment with other cancer medications

OPDIVO Qvantig cannot be used in combination with YERVOY. OPDIVO, OPDIVO-based combination treatments, OPDIVO Qvantig, and OPDIVO Qvantig-based combination treatments will not work for everyone. Individual results may vary.

Hands exploring how OPDIVO® (nivolumab) works and learning how this treatment may help fight cancer.

How treatment works

See how this treatment may help your body fight cancer

OPDIVO® (nivolumab) side effects.

Side effects

View side effects of treatment and learn how to manage them

See treatment plans and what to expect from an OPDIVO® IV infusion or OPDIVO® QVANTIG™ subcutaneous injection.

Getting treatment

See treatment plans and what to expect from an intravenous (IV) infusion or under-the-skin injection (subcutaneous injection)



466-US-2500012   04/25